Sodium bicarbonate, may help stabilize kidney function in patients with chronic kidney disease. However, the optimal dose for testing this possibility in a clinical trial is uncertain. The BASE pilot clinical trial will help determine the best dose of sodium bicarbonate to use in a future study that will test the long-term safety and efficacy of sodium bicarbonate as a treatment to preserve kidney function in individuals with chronic kidney disease. The two doses of sodium bicarbonate being tested are 0.5 and 0.8 mEq/kg-lean body weight (LBW) per day.
|Effective start/end date||1/1/17 → 4/30/19|
- Veterans Medical Research Foundation of San Diego (08649005-321072//5U01DK97093-05)
- National Institute of Diabetes and Digestive and Kidney Diseases (08649005-321072//5U01DK97093-05)